P372: DISMAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER FAILURE OF BOTH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB

• W. Macaron,
• E. Jabbour,
• M. Konopleva,
• F. Ravandi,
• N. Jain,
• G. Issa,
• T. Kadia,
• K. Sasaki,
• P. Kebriaei,
• M. Yilmaz,
• P. Thompson,
• K. Takahashi,
• H. Abbas,
• W. Wierda,
• R. Garris,
• H. Kantarjian,
• N. Short

Affiliations

W. Macaron

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

E. Jabbour

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

M. Konopleva

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

F. Ravandi

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

N. Jain

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

G. Issa

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

T. Kadia

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

K. Sasaki

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

P. Kebriaei

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

M. Yilmaz

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

P. Thompson

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

K. Takahashi

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

H. Abbas

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

W. Wierda

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

R. Garris

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

H. Kantarjian

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

N. Short

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America